Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 8 trials

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (3)
P 1 (1)
P 3 (1)
P 4 (1)

Trial Status

Recruiting4
Not Yet Recruiting2
Active Not Recruiting1
Unknown1

Clinical Trials (8)

Showing 8 of 8 trials
NCT07322848Phase 3Recruiting

DEB-TACE vs cTACE in HCC After TIPS

NCT07454408Phase 1Not Yet Recruiting

Evaluation of the Outcome of Fecal Microbiota Transplantation

NCT07437638Active Not Recruiting

Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis

NCT07058155Phase 4Recruiting

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

NCT07273734Not ApplicableNot Yet Recruiting

UDCA to Prevent Post-TIPS Hepatic Encephalopathy

NCT07163689RecruitingPrimary

TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease

NCT06814990Not ApplicableRecruiting

Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement

NCT04207398Not ApplicableUnknown

TIPS vs. NSBB Plus Endotherapy for the Prevention of Variceal Rebleeding in NSBB Non-responders of Primary Prophylaxis

Showing all 8 trials

Research Network

Activity Timeline